These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15999692)
1. [Role of hypertension in the progression of diabetic microangiopathy]. Kamide K; Rakugi H Nihon Rinsho; 2005 Jun; 63 Suppl 6():98-102. PubMed ID: 15999692 [No Abstract] [Full Text] [Related]
2. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor]. Higashiura K; Shimamoto K Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698 [No Abstract] [Full Text] [Related]
3. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension. Tocci G; Sciarretta S; Facciolo C; Volpe M Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654 [TBL] [Abstract][Full Text] [Related]
4. [Contribution of diuretics to the treatment of hypertension in patients with CKD]. Ura N; Yamaji I Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551 [No Abstract] [Full Text] [Related]
5. The Renin-Angiotensin system and vascular disease in diabetes. Deinum J; Chaturvedi N Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606 [TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive drugs in diabetic's hypertension]. Pugliese F G Ital Nefrol; 2006; 23 Suppl 34():S26-31. PubMed ID: 16633991 [TBL] [Abstract][Full Text] [Related]
8. A vaccine for hypertension. Ménard J J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170 [No Abstract] [Full Text] [Related]
9. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic effect of blockade of the renin-angiotensin system. Ando K; Fujita T Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746 [TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. Kolesnyk I; Struijk DG; Dekker FW; Krediet RT Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy? Weber MA; Giles TD Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123 [TBL] [Abstract][Full Text] [Related]
15. [Debate concerning the optimal blockage of the renin-angiotensin system]. Choukroun G Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454 [No Abstract] [Full Text] [Related]
16. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system]. Boucek P Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602 [TBL] [Abstract][Full Text] [Related]
17. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies]. Katayama S Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740 [No Abstract] [Full Text] [Related]
18. Renin-angiotensin-system blockade in the prevention of diabetes. Ostergren J Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999 [TBL] [Abstract][Full Text] [Related]
19. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Krum H; Gilbert RE J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168 [TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker]. Schindler C; Kosa M; Schröder J; Kirch W Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385 [No Abstract] [Full Text] [Related] [Next] [New Search]